Full Text View
Tabular View
No Study Results Posted
Related Studies
A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine
This study has been completed.
Study NCT01358968   Information provided by Eli Lilly and Company

First Received on May 20, 2011.   Last Updated on January 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Interventions listed in this trial
LY2603618
Desipramine
Pemetrexed
Gemcitabine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Anti-Infective Agents
Antidepressive Agents
Antidepressive Agents, Tricyclic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Central Nervous System Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services